High levels of oncomiR‐21 contribute to the senescence‐induced growth arrest in normal human cells and its knock‐down increases the replicative lifespan
Abstract:Cellular senescence of normal human cells has by now far exceeded its initial role as a model system for aging research. Many reports show the accumulation of senescent cells in vivo, their effect on their microenvironment and its double-edged role as tumour suppressor and promoter. Importantly, removal of senescent cells delays the onset of age-associated diseases in mouse model systems. To characterize the role of miRNAs in cellular senescence of endothelial cells, we performed miRNA arrays from HUVECs of fi… Show more
“…In addition, upregulation of mir-26a, mir-29a and mir-23a (Boon et al ., 2011; Dellago et al ., 2013) has been reported in aging mice and humans. One of the miRNAs showing the highest increase was mir-34b-3p.…”
Section: Resultsmentioning
confidence: 97%
“…RTEF-1 targets genes such as VEGF and HIF-1α in endothelial cells under hypoxia and increases vascular relaxation by modulating eNOS (Dellago et al ., 2013; Zhu et al ., 2013). In addition, previous studies have shown that VEGF promoter activity is reduced in aged animals (Rivard et al ., 1999).…”
Increasing evidence suggests that microRNAs (miRNAs) play important roles in impaired endothelial cell (EC) angiogenesis during aging. However, their exact roles in the aging process remain unclear. We aimed to determine whether miRNAs cause angiogenesis defects in ECs during aging and to uncover the underlying mechanisms. To study the miRNA-induced changes in ECs during aging, we performed microarray analyses on arterial ECs collected from young and aging mice. Using qRT–PCR, we showed that microRNA-125a-5p (mir-125a-5p) expression was approximately 2.9 times higher in old endothelial cells (OECs) compared with samples collected from young animals. Western blot assays showed a lower expression level of an mir-125a-5p target known as related transcriptional enhancer factor-1 (RTEF-1) in OECs compared with its expression levels in young cells. Overexpression of mir-125a-5p in young endothelial cells (YECs) using pre-mir-125a-5p caused the downregulation of RTEF-1, endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) and resulted in impaired angiogenesis, as evidenced by spheroid sprouting and tube formation assays in vitro. Conversely, repression of mir-125a-5p in OECs using anti-mir-125a-5p increased RTEF-1, eNOS and VEGF expression and improved EC angiogenesis. Importantly, impaired angiogenesis caused by knock-down of RTEF-1 was not efficiently rescued by anti-mir-125a-5p. Dual-luciferase reporter gene analysis showed that RTEF-1 is a direct target of mir-125a-5p, which regulates angiogenesis by repressing RTEF-1 expression and modulating eNOS and VEGF expression. These findings indicate that mir-125a-5p and RTEF-1 are potential therapeutic targets for improving EC-mediated angiogenesis in elderly individuals.
“…In addition, upregulation of mir-26a, mir-29a and mir-23a (Boon et al ., 2011; Dellago et al ., 2013) has been reported in aging mice and humans. One of the miRNAs showing the highest increase was mir-34b-3p.…”
Section: Resultsmentioning
confidence: 97%
“…RTEF-1 targets genes such as VEGF and HIF-1α in endothelial cells under hypoxia and increases vascular relaxation by modulating eNOS (Dellago et al ., 2013; Zhu et al ., 2013). In addition, previous studies have shown that VEGF promoter activity is reduced in aged animals (Rivard et al ., 1999).…”
Increasing evidence suggests that microRNAs (miRNAs) play important roles in impaired endothelial cell (EC) angiogenesis during aging. However, their exact roles in the aging process remain unclear. We aimed to determine whether miRNAs cause angiogenesis defects in ECs during aging and to uncover the underlying mechanisms. To study the miRNA-induced changes in ECs during aging, we performed microarray analyses on arterial ECs collected from young and aging mice. Using qRT–PCR, we showed that microRNA-125a-5p (mir-125a-5p) expression was approximately 2.9 times higher in old endothelial cells (OECs) compared with samples collected from young animals. Western blot assays showed a lower expression level of an mir-125a-5p target known as related transcriptional enhancer factor-1 (RTEF-1) in OECs compared with its expression levels in young cells. Overexpression of mir-125a-5p in young endothelial cells (YECs) using pre-mir-125a-5p caused the downregulation of RTEF-1, endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) and resulted in impaired angiogenesis, as evidenced by spheroid sprouting and tube formation assays in vitro. Conversely, repression of mir-125a-5p in OECs using anti-mir-125a-5p increased RTEF-1, eNOS and VEGF expression and improved EC angiogenesis. Importantly, impaired angiogenesis caused by knock-down of RTEF-1 was not efficiently rescued by anti-mir-125a-5p. Dual-luciferase reporter gene analysis showed that RTEF-1 is a direct target of mir-125a-5p, which regulates angiogenesis by repressing RTEF-1 expression and modulating eNOS and VEGF expression. These findings indicate that mir-125a-5p and RTEF-1 are potential therapeutic targets for improving EC-mediated angiogenesis in elderly individuals.
“…miR-23a was previously reported to be upregulated in replicative senescent human umbilical vein endothelial cells and human umbilical cord blood-derived multipotent stem cells (Lee et al ., 2011; Dellago et al ., 2013). In senescent BJ and MC-5 human fibroblast cells, we also observed upregulated miR-23a levels; additionally, a concomitant reduction of TRF2 expression in both mRNA and protein levels was also apparent.…”
Telomeric repeat binding factor 2 (TRF2) is essential for telomere maintenance and has been implicated in DNA damage response and aging. Telomere dysfunction induced by TRF2 inhibition can accelerate cellular senescence in human fibroblasts. While previous work has demonstrated that a variety of factors can regulate TRF2 expression transcriptionally and post-translationally, whether microRNAs (miRNAs) also participate in post-transcriptionally modulating TRF2 levels remains largely unknown. To better understand the regulatory pathways that control TRF2, we carried out a large-scale luciferase reporter screen using a miRNA expression library and identified four miRNAs that could target human TRF2 and significantly reduce the level of endogenous TRF2 proteins. In particular, our data revealed that miR-23a could directly target the 3′ untranslated region (3′UTR) of TRF2. Overexpression of miR-23a not only reduced telomere-bound TRF2 and increased telomere dysfunction-induced foci (TIFs), but also accelerated senescence of human fibroblast cells, which could be rescued by ectopically expressed TRF2. Our findings demonstrate that TRF2 is a specific target of miR-23a, and uncover a previously unknown role for miR-23a in telomere regulation and cellular senescence.
“…A recent study has shown that among several up-regulated miRNA during replicative or premature senescence of normal human endothelial cells was miR-21 (Dellago et al 2013 ). Transfection of miR-21 into early passage cells induced senescence, up-regulation of p21…”
The epigenetics of aging is a relatively new fi eld. Global DNA methylation has been examined for some time; however, only recently have age-related differentially methylated regions been elaborated. These regions encompass genes that in some cases interact with longevity and disease-associated genes. Histone modifi cations have now become of interest in aging studies. Model organisms have provided substantial evidence that some of the enzymes that are involved in histone modifi cations play a role in longevity, and direct evidence of such a role for one of the sirtuins has been gathered in mice. A number of studies examining expression of microRNA during aging in various organisms, including human, point to the possibility that these gene regulatory molecules may also be involved in aging. A recent study of one such microRNA in mice substantiates such a role in cardiac aging. All of these epigenetic mechanisms are responsive to environmental and lifestyle factors. Thus, the groundwork has been laid for an understanding of the interface between the genome and the environment that epigenetic mechanisms provide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.